Physician profile
Robert M Kipperman
NPI 1942297908
$47,914.38
in general payments reported to CMS, 2019-2025
26 companies · $6,837 in 2025
The $6,837 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $2,359 · 2021: $5,595 · 2022: $4,114 · 2023: $6,407 · 2024: $8,309 · 2025: $6,837.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19K · Travel and Lodging: $2,497 · Long Term Medical Supply Or Device Loan: $282 · Entertainment: $16.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18,757.88 |
| Travel and Lodging | $2,497.26 |
| Long Term Medical Supply Or Device Loan | $281.66 |
| Entertainment | $16.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $18,969.59 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal |
| Medtronic, INC. | $11,229.63 | 2021-2025 | Corevalve Evolut R, Na, Apollotm |
| Medtronic Vascular, INC. | $8,640.80 | 2019-2020 | |
| Abbott Laboratories | $5,054.96 | 2019-2025 | Navitor, Portico, Mitraclip |
| Boston Scientific Corporation | $873.96 | 2019-2025 | Watchman Flx, Watchman Access System, Watchman |
| Aop Health US, LLC | $509.74 | 2025 | Rapiblyk |
| W. L. Gore & Associates, INC. | $509.34 | 2019-2025 | Gore Cardioform Septal Occluder, Gore Cardioform Asd Occluder |
| Irhythm Technologies, INC. | $391.70 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Saranas, INC. | $332.26 | 2021 | |
| Heartflow, INC. | $238.96 | 2019 | |
| Cardiva Medical, INC. | $221.93 | 2024-2025 | Savvywire, Other, Cardiva Vascade 6/7f Vcs |
| Shockwave Medical, INC | $180.36 | 2025 | |
| Pfizer INC. | $169.72 | 2021-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $137.97 | 2019-2023 | Lifevest |
| Stryker Corporation | $109.82 | 2025 | Flowtriever |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $87.43 | 2022-2025 | Eliquis, Camzyos |
| Cardiovascular Systems INC. | $62.21 | 2019-2022 | |
| Philips North America LLC | $45.46 | 2024-2025 | Extended Holter, (5044) Mcot |
| Astrazeneca Pharmaceuticals Lp | $41.08 | 2019-2022 | |
| Opsens INC. | $31.57 | 2022-2023 | Optowire |
| Abiomed | $28.42 | 2019 | |
| Kestra Medical Technology Services, INC. | $16.79 | 2024 | Assure Wcd |
| Amgen INC. | $16.60 | 2024 | Repatha |
| Janssen Pharmaceuticals, INC | $14.08 | 2024 | Xarelto |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kipperman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.